title: Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.
abstract: BACKGROUND
  Myofibroblasts, a derived subset of fibroblasts especially important in scar formation and wound contraction, have been found at elevated levels in affected Dupuytren's tissues. Transformation of fibroblasts to myofibroblasts is characterized by expression of alpha- smooth muscle actin (α-SMA) and increased production of extracellular matrix (ECM) components, both events of relevance to connective tissue remodeling. We propose that increasing the activation of the cyclic AMP (cAMP)/protein kinase A signaling pathway will inhibit transforming growth factor-beta1 (TGF-β1)-induced ECM synthesis and myofibroblast formation and may provide a means to blunt fibrosis.
  
  
  METHODS
  Fibroblasts derived from areas of Dupuytren's contracture cord (DC), from adjacent and phenotypically normal palmar fascia (PF), and from palmar fascia from patients undergoing carpal tunnel release (CTR; CT) were treated with TGF-β1 (2 ng/ml) and/or forskolin (10 μM) (a known stimulator of cAMP). Total RNA and protein extracted was subjected to real time RT-PCR and Western blot analysis.
  
  
  RESULTS
  The basal mRNA expression levels of fibronectin- extra domain A (FN1-EDA), type I (COL1A2) and type III collagen (COL3A1), and connective tissue growth factor (CTGF) were all significantly increased in DC- and in PF-derived cells compared to CT-derived fibroblasts. The TGF-β1 stimulation of α-SMA, CTGF, COL1A2 and COL3A1 was greatly inhibited by concomitant treatment with forskolin, especially in DC-derived cells. In contrast, TGF-β1 stimulation of FN1-EDA showed similar levels of reduction with the addition of forskolin in all three cell types.
  
  
  CONCLUSIONS
  In sum, increasing cAMP levels show potential to inhibit the formation of myofibroblasts and accumulation of ECM components. Molecular agents that increase cAMP may therefore prove useful in mitigating DC progression or recurrence.
authors: Center for Genomic Sciences, Allegheny-Singer Research Institute, Pittsburgh, PA-15212, USA. lsatish@wpahs.org
authors: Latha
authors: L
authors: Satish
authors: Phillip H
authors: PH
authors: Gallo
authors: Mark E
authors: ME
authors: Baratz
authors: Sandra
authors: S
authors: Johnson
authors: Sandeep
authors: S
authors: Kathju
references: J Biol Chem. 2001 May 18;276(20):17058-62
references: 11279127
references: J Hand Surg Am. 2000 Nov;25(6):1157-62
references: 11119679
references: Arch Otolaryngol Head Neck Surg. 2007 Sep;133(9):919-24
references: 17875859
references: Histochem J. 1995 Dec;27(12):1014-20
references: 8789403
references: Am J Physiol. 1999 Aug;277(2):C183-201
references: 10444394
references: J Clin Pathol. 1993 May;46(5):425-8
references: 8320323
references: Am J Physiol Cell Physiol. 2004 May;286(5):C1089-99
references: 15075208
references: J Hand Surg Br. 2002 Jun;27(3):270-3
references: 12074617
references: J Surg Res. 2004 Apr;117(2):232-8
references: 15047128
references: J Biol Chem. 2007 Apr 6;282(14):10405-13
references: 17317656
references: J Bone Joint Surg Am. 1976 Apr;58(3):380-7
references: 1262372
references: J Cell Physiol. 2005 May;203(2):447-56
references: 15605379
references: N Engl J Med. 2009 Sep 3;361(10):968-79
references: 19726771
references: J Hand Surg Am. 1996 Mar;21(2):210-5
references: 8683048
references: J Hand Surg Am. 1978 Jan;3(1):1-10
references: 621363
references: J Bone Joint Surg Am. 1980 Apr;62(3):425-32
references: 7364813
references: J Biol Chem. 2010 Jan 1;285(1):409-21
references: 19858184
references: Hand Clin. 1999 Feb;15(1):21-34
references: 10050239
references: Hand (N Y). 2008 Jun;3(2):80-6
references: 18780081
references: J Hand Surg Br. 2006 Oct;31(5):514-21
references: 16837113
references: Nat Cell Biol. 2002 Aug;4(8):599-604
references: 12134160
references: J Hand Surg Am. 1995 Jan;20(1):101-8
references: 7722248
references: J Hand Surg Am. 1994 May;19(3):435-41
references: 7520050
references: J Bone Joint Surg Br. 1999 Jul;81(4):732-8
references: 10463754
references: Exp Cell Res. 1999 Aug 1;250(2):273-83
references: 10413583
references: J Bone Joint Surg Br. 2003 Apr;85(3):448-55
references: 12729127
references: Annu Rev Biochem. 1997;66:807-22
references: 9242925
references: BMC Med Genomics. 2008 Apr 23;1:10
references: 18433489
references: Wound Repair Regen. 2008 Sep-Oct;16(5):661-73
references: 19128261
references: Annu Rev Physiol. 1994;56:237-72
references: 8010741
references: J Bone Joint Surg Am. 1959 Jun;41-A(4):635-64
references: 13664703
references: Cytokine Growth Factor Rev. 1997 Sep;8(3):171-9
references: 9462483
references: Br J Hosp Med (Lond). 2007 Nov;68(11):604-9
references: 18087853
references: J Biol Chem. 2001 Apr 6;276(14):10594-601
references: 11152469
references: J Hand Surg Am. 1994 May;19(3):442-52
references: 8056971
references: J Cell Physiol. 2007 Mar;210(3):843-52
references: 17133352
references: J Biol Chem. 2004 Feb 20;279(8):6959-66
references: 14645373
references: Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):437-42
references: 15625103
references: Chir Main. 2000 Feb;19(1):15-22
references: 10777424
references: Hand Clin. 1999 Feb;15(1):97-107, vii
references: 10050246
references: J Hand Surg Br. 2004 Feb;29(1):18-21
references: 14734063
references: J Biol Chem. 2003 Apr 11;278(15):13008-15
references: 12571253
references: J Hand Surg Am. 2007 Jul-Aug;32(6):767-74
references: 17606053
references: Oncogene. 2003 Dec 4;22(55):8881-90
references: 14654784